Businessweek article: FDA considers stockpiling Levaquin & Cipro.

Businessweek article.
The FDA considers increasing stockpiles of Levaquin & Cipro. The FDA will hear arguments for the wider availability of ciprofloxacin and Johnson & Johnson (JNJ) Levaquin to treat any terrorist-initiated outbreak of pneumonic plague, according to documents on the FDA’s website.
Be Sociable, Share!
You can leave a response, or trackback from your own site.

One Response to “Businessweek article: FDA considers stockpiling Levaquin & Cipro.”

  1. JD says:

    That’s great, they are finally making use of the medication for what’s it’s made for rather than handing it out to us all like candy like they have been. hopefully they’ll warn people some may become disabled.

Leave a Reply

Design by Aaron Melvin